Amgen, AstraZeneca strike drug development deal
Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →
Sientra funding rises to $151M
Sientra, the Santa Barbara breast implant company that recently received the first FDA approval in several decades for new implants for the U.S. market, has closed a $65 million funding round, bringing its total capital raised to $151 million. The lead investor on the private equity deal was London-based life sciences fund Abingworth. Sientra’s existing Read More →
Bill Gates: New nuclear could be “energy miracle”
Microsoft founder Bill Gates is placing his chips on nuclear technology these days.
A new player in Silicone Alley: Sientra enters breast implant industry
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Clipper Windpower up for sale
Less than two years after Clipper Windpower was purchased by defense-industrial giant United Technologies Corp., the Carpinteria-based turbine maker is up for sale again. United Technologies, the name behind Pratt & Whitney jet engines and Sikorsky helicopters, bought Clipper in 2010 as the company was struggling to keep its cash flowing. The defense giant paid Read More →
